It's Not Just Diabetes Patients Who Need Glucose Monitoring During This Pandemic
DiabetesIt's Not Just Diabetes Patients Who Need Glucose Monitoring During This PandemicIt's Not Just Diabetes Patients Who Need Glucose Monitoring During This Pandemic
MD+DI spoke with Dexcom CEO Kevin Sayer about why continuous glucose monitoring (CGM) is so important in the COVID-19 fight, how the company is managing hospital demand with existing patient needs, and the potential opportunity this creates for using CGMs in the hospital setting down the road.
Sign up for the QMED & MD+DI Daily newsletter.